SCHMC

Protein kinase, membrane‑associated tyrosine/threonine1 is associated with the progression of colorectal cancer

Metadata Downloads
Abstract
The protein kinase, membrane‑associated tyrosine/threonine1 (PKMYT1) is known to inhibit precocious entry into mitosis by phosphorylating CDK1 at Thr14 and Tyr15 residues. However, the functional importance of PKMYT1 in colorectal cancer (CRC) remains unknown. Thus, it is important to elucidate whether PKYMT1 is indispensable in the tumorigenesis of CRC. To investigate the functional importance of PKMYT1 in CRC tumorigenesis, PKMYT1 was knocked down in CRC cell lines such as SW480, SW620, HCT116 and HT29 by siRNA. PKMYT1‑depleted CRC cells were analyzed to determine proliferation, migration, invasion and colony forming ability. In addition, 179patient‑derived samples were used to find the correlation of the expression of PKMYT1 with the prognosis of CRC patients. By siRNA‑mediated loss of function of PKMYT1, we observed that proliferation, migration, invasion and colony forming ability of CRC cell lines were significantly impaired in the absence of PKMYT1 invitro. Furthermore, by analyzing patient‑derived samples, we revealed the association of PKMYT1 with the overall survival rate of CRC patients. These results indicated that PKMYT1 plays an essential oncogenic role in CRC and could serve as a good therapeutic target for the treatment of CRC.
All Author(s)
D. Jeong ; H. Kim ; D. Kim ; S. Ban ; S. Oh ; S. Ji ; D. Kang ; H. Lee ; T. S. Ahn ; H. J. Kim ; S. B. Bae ; M. S. Lee ; C. J. Kim ; H. Y. Kwon ; M. J. Baek
Issued Date
2018
Type
Article
Keyword
PKMYT1colorectal cancerprognosismetastasis
Publisher
Ethnikon Hidryma Ereunōn (Greece)
ISSN
1021-335X ; 1791-2431
Citation Title
Oncology Reports
Citation Volume
39
Citation Number
6
Citation Start Page
2829
Citation End Page
2836
Language(ISO)
eng
DOI
10.3892/or.2018.6371
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/2553
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.